Steven Nissen

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be untreatable, for up to one year.

The latest science on how blood levels of HDL, LDL and more relate to cardiovascular health

The latest study of statins and diabetes risk points to a small increased risk for new-onset diabetes with rosuvastatin vs atorvastatin, but experts advise caution in interpreting the results.

Drug lowers LDL cholesterol and reduces the risk of serious cardiovascular outcomes in a large trial. The cholesterol-lowering drug bempedoic acid reduced the combined rate of major adverse cardiovascular events by 13%, meeting its primary endpoint in a large study of patients with high cholester

Testosterone replacement therapy is safe for men with "low T" who have heart disease or are at high risk for it, a new study suggests. The research...

New research suggests testosterone replacement therapy is safe for men with "low T"...

Bempedoic acid was approved by the FDA in 2020 as a way to reduce LDL cholesterol levels.

Rocky regulatory road lies ahead for the cardiac myosin activator

A single pill that combines several heart medications like blood pressure drugs, statins and blood thinner - known as polypill - reduced risk of death in some heart patients.

Researchers found that subjects who underwent weight loss surgery also showed a sharp decrease in their likelihood of dying from cancer.

Findings from a phase 1 trial show that an experimental 'gene silencing' therapy reduced blood levels of lipoprotein(a), a key driver of heart disease risk, by up to 98%.

We asked experts on what are the benefits and risks of taking the highly touted supplement. This is what they said

Researchers hope reducing Lp(a) levels will also reduce risk of heart attack and stroke

In October 2024, NASA's Office of the Chief Health and Medical Officer (OCHMO) initiated a working group to review the status and progress of research and

Bariatric surgery reduces the progression to decompensated cirrhosis and the risk for major adverse liver outcomes, such as cancer and transplantation.

Surgery reduced risk of liver decompensation by 80%

A new approach to a routine blood test could predict a person's 30-year risk of heart disease, research published Saturday in the New England Journal of Medicine found.

Quotable quotes heard by MedPage Today's reporters

Treatment with the aldosterone synthase inhibitor lorundrostat significantly decreased automated office systolic blood pressure in adults with uncontrolled hypertension in the phase 2 TARGET-HTN trial.

Bempedoic acid, a statin alternative, may help reduce deaths from heart disease among people with high levels of "bad" cholesterol, new research finds.